Partners
Renishaw
Exhibition Partner
Renishaw Neuro Solutions enables direct-to-target delivery for a broad range of applications. Using the neuroinfuse™ drug delivery system, predictable and translatable therapy infusions in R&D and clinical trials can become a reality. Our Lab2Clinic™ service supports pharma through the R&D journey, translating into clinical trials and scaled-up commercialisation. We have a wide geographical reach, and we focus on promoting long-term partnerships. All this is underpinned by our FDA-cleared, CE-marked stereotatic products borne out of a +45-year precision engineering heritage.
End Brain Cancer Initiative
Exhibition Partner
The End Brain Cancer Initiative (EBCI), formerly the Chris Elliott Fund, www.EndBrainCancer. org, is a 501 (c)3 non-profit Patient Advocacy organization focused on early drug development and increasing patient and care partner access to advanced treatments, diagnostics, devices, technology, clinical trials, etc. and on advancing and turning science and data into additional FDA approved treatment options for cancer patients, including patients with brain tumors, brain cancer and metastasized disease to the brain and again, increasing patient access through commercialization and reimbursement efforts.